Cargando…
Trans-presentation of interleukin-6 by dendritic cells is required for priming pathogenic T(H)17 cells
The cellular sources of interleukin-6 (IL-6) that are relevant for the differentiation of T(H)17 cells remain unclear. Here, we used a novel strategy of IL-6 conditional deletion of distinct IL-6-producing cell types to show that Sirpα(+) dendritic cells (DC) were essential for the generation of pat...
Autores principales: | Heink, Sylvia, Yogev, Nir, Garbers, Christoph, Herwerth, Marina, Aly, Lilian, Gasperi, Christiane, Husterer, Veronika, Croxford, Andrew L., Möller-Hackbarth, Katja, Bartsch, Harald S., Sotlar, Karl, Krebs, Stefan, Regen, Tommy, Blum, Helmut, Hemmer, Bernhard, Misgeld, Thomas, Wunderlich, Thomas F., Hidalgo, Juan, Oukka, Mohamed, Rose-John, Stefan, Schmidt-Supprian, Marc, Waisman, Ari, Korn, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5164931/ https://www.ncbi.nlm.nih.gov/pubmed/27893700 http://dx.doi.org/10.1038/ni.3632 |
Ejemplares similares
-
In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica‐related pathology
por: Herwerth, Marina, et al.
Publicado: (2016) -
P2R Inhibitors Prevent Antibody-Mediated Complement Activation in an Animal Model of Neuromyelitis Optica: P2R Inhibitors Prevent Autoantibody Injury
por: Kalluri, Sudhakar Reddy, et al.
Publicado: (2022) -
Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE
por: Rothhammer, Veit, et al.
Publicado: (2011) -
A new form of axonal pathology in a spinal model of neuromyelitis optica
por: Herwerth, Marina, et al.
Publicado: (2022) -
From Leflunomide to Teriflunomide: Drug Development and Immuno-suppressive Oral Drugs in the Treatment of Multiple Sclerosis
por: Aly, Lilian, et al.
Publicado: (2017)